Clinical Trial

Exercise, Hypertension, and Gut Dysbiosis in African Americans

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
African Americans have the greatest burden of endothelial dysfunction and hypertension. Recently, gut microbial dysbiosis (a term that describes a poorly diverse gut microbial profile and lower short-chain fatty acid (SCFA) production) has been linked to hypertension and may be involved in the pathogenesis of hypertension in African Americans. African Americans have been reported to have lower gut SCFA and SCFA can reduce blood pressure. Exercise reduces blood pressure and improves gut dysbiosis (increases SCFA) and likely couples' improvements in gut microbial health and vascular function to reduce blood pressure. Thus, the goals of this research are to fill a critical void concerning the interaction of gut dysbiosis, hypertension, and utilizing exercise to identify gut microbial adaptations that accompany a reduction in blood pressure. The short-term implications of this work will advance the clinical communities understanding of the relationship between dysbiosis and the pathogenesis of hypertension in African Americans, while long term implications will promote identifying adaptable gut microbes associated with vascular health to aid in amending treatment strategies for hypertension.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-03-28; most recent amendment 2026-04-08.
Status change: Recruiting → Active, Not Recruiting 2023-03-21
Status change: Not Yet Recruiting → Recruiting 2020-04-15
Trial Details
NCT Number NCT03897777
Lead Sponsor North Carolina Agriculture & Technical State University
Conditions Hypertension
Enrollment 36 participants
Start Date 2019-06-01
Primary Completion 2030-06 (estimated)
Study Completion 2030-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-13